TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/24 16:31 | 10/1/24 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Karabelas Argeris N | MD | D | S.d | -101 | 10.11 | 0 | -10 | -47 | 11 | D | ||||||||||||||||
9/4/24 20:20 | 9/3/24 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Karabelas Argeris N | MD | D | S.d | -116 | 11.56 | 0 | -10 | -47 | 11 | D | ||||||||||||||||
8/5/24 18:39 | 8/1/24 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Karabelas Argeris N | MD | D | S.d | -136 | 13.51 | 0 | -10 | -47 | 11 | D | ||||||||||||||||
7/30/24 17:01 | 7/29/24 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Karabelas Argeris N | MD | D | S.d | -165 | 15.05 | 0 | -11 | -49 | 11 | D | ||||||||||||||||
7/3/24 07:55 | 7/1/24 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Karabelas Argeris N | MD | D | S.d | -113 | 11.27 | 0 | -10 | -47 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |